COVID-19/Flu A&B Rapid Immunoassay yeKuonekwa Kwakananga

COVID-19/Flu A&B Rapid Immunoassay yeKuonekwa Kwakananga,
COVID-19/Flu A&B Rapid Immunoassay yeKuonekwa Kwakananga,

Product details

Chinangwa Kushandiswa
SARS-CoV-2 & Influenza A/B Antigen Combo Rapid Test Kit (Lateral chromatography) inofanirwa kushandiswa pamwe chete nekuratidzwa kwekiriniki uye mamwe mhedzisiro yekuongororwa murabhoritari kubatsira mukuongororwa kwevarwere vane vanofungidzirwa kuti SARS-CoV-2 kana Influenza A. /B utachiona.Muedzo unongoshandiswa nenyanzvi dzekurapa.Inongopa yekutanga yekuongorora mhedzisiro uye dzimwe nzira dzekuongororwa dzinofanirwa kuitwa kuitira kuti uwane humbowo hweSARS-CoV-2 kana Influenza A/B hutachiona.Yekushandisa nyanzvi chete.

Test Principle
SARS-CoV-2 & Influenza A/B Antigen Combo Rapid Test Kit (Lateral chromatography) is a lateral flow chromatographic immunoassay.Iine mhinduro mbiri Windows.Kuruboshwe kune SARS-CoV-2 antigens.Iine mitsetse miviri isati yavharwa, "T" Test line uye "C" Control line pane nitrocellulose membrane.Kurudyi kune hwindo remhedzisiro yeFluA/FluB, ine mitsara mitatu yakavharwa, "T1" FluA Test line, "T2" FluB Test line uye "C" Kudzora mutsara pane nitrocellulose membrane.

Main Contents

Zvikamu zvakapihwa zvakanyorwa patafura.

Operation Flow

• Danho 1: Sampling

Rereka musoro wemurwere kumashure 70 madhigirii.Nyatsopinza swab mumhino kusvika swab yasvika kuseri kwemhino.Siya swab mumhino yega yega kwemasekonzi mashanu kuti utore zvakabuda.

• Danho rechipiri: Kuedza

1. Bvisa chubhu yekubvisa kubva pakiti uye bhokisi rekuedza kubva muhombodo yefirimu nekubvarura notch.Zviise pahorizontal ndege.

2. Mushure mekuenzanisa, sora iyo smear pazasi peyero yemvura yemuenzaniso wekubvisa buffer, tenderera uye dzvanya kashanu.Kunyura nguva yekuzora kanenge 15s.

3. Bvisa swab uye wodzvanya kumucheto kwechubhu kuti usvine kunze kwemvura mumucheka.Kanda swab mumarara ane ngozi.

4. Gadzirisa chifukidzo chepipette zvakasimba pamusoro peputi yekusveta.Zvadaro zvinyoro shandura chubhu yekubvisa ka5.

5. Tumira 2 kusvika ku3 madonhwe (anenge 100 ul) yemuenzaniso kune sampuli yepamusoro yebhendi rekuedza uye tanga timer.Ongorora: kana masampuli akaomeswa akashandiswa, masampula anofanira kunge aine tembiricha yekamuri.

• Danho rechitatu: Kuverenga

15 mins gare gare, verenga zvabuda uchizviona.(Cherechedza: USAverenge zvawanikwa mushure memaminitsi makumi maviri!)

Tsanangudzo yemhedzisiro

1.SARS-CoV-2 Positive Result

Mabhendi ane mavara anoonekwa pane ese ari maviri bvunzo mutsetse (T) uye control line (C).Zvinoratidza a

mhedzisiro yakanaka yeSARS-CoV-2 maantigen mune sampuli.

2.FluA Positive Result

Mabhendi ane mavara anoonekwa pane ese ari maviri bvunzo mutsetse (T1) uye control line (C).Zvinoratidza

mhedzisiro yakanaka yeFluA antigens mumuenzaniso.

3.FluB Positive Result

Mabhendi ane mavara anoonekwa pane ese ari maviri bvunzo mutsetse (T2) uye control line (C).Zvinoratidza

Mhedzisiro yakanaka yeFluB antigens mumuenzaniso.

4.Negative Result

Rudzi bhendi rinoonekwa pamutsetse wekutonga (C) chete.Zvinoratidza kuti

kusangana kweSARS-CoV-2 uye FluA/FluB maantigens haapo kana

pasi pemuganho wekuona webvunzo.

5.Invalid Result

Hapana bhendi reruvara rinooneka rinoonekwa pamutsetse wekutonga mushure mekuita bvunzo.The

nzira dzinogona kunge dzisina kuteverwa nemazvo kana bvunzo inogona kunge yakaita

deteriorated.Zvinokurudzirwa kuti muenzaniso uongororwe zvakare.

Order Information

COVID-19/Flu A&B bvunzo ndeye lateral kuyerera immunoassay yakagadzirirwa iyo in vitro nekukurumidza, panguva imwe chete kunaka.
kucherechedzwa nekusiyaniswa kwenucleocapsid antigen kubva kuSARS-CoV-2, furuwenza A uye/kana furuwenza B zvakananga kubva kumberi.
nasal kana nasopharyngeal swab samples dzakatorwa kubva kuvanhu, avo vanofungidzirwa kuti vane hutachiona hwekufema.
zvinoenderana neCCIDID-19 nemupi wehutano, mukati memazuva mashanu ekutanga ekutanga kwezviratidzo.Clinical zviratidzo uye
zviratidzo zvekufema kwehutachiona hwehutachiona nekuda kweSARS-CoV-2 uye furuwenza zvinogona kufanana.Kuongororwa kunogumira kumarabhoritari
yakasimbiswa pasi peClinical Laboratory Improvement Amendments ye1988 (CLIA), 42 USC §263a, inosangana ne
zvinodiwa kuita zviri pakati nepakati, zvepamusoro, kana waived kuomarara bvunzo.Ichi chigadzirwa chinotenderwa kushandiswa paPoint of Care
(POC), kureva, munzvimbo dzekuchengetedza varwere dzinoshanda pasi peCLIA Certificate yeWaiver, Certificate of Compliance, kana Certificate ye
Kubvumirwa.